FDCDDQ
HBIO icon

Federation des caisses Desjardins du Quebec’s Harvard Bioscience HBIO Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,614
Closed -$36.1K – 2172
2020
Q1 		$36.1K Hold
1,614
– – ﹤0.01% 1343
2019
Q4 		$49.2K Hold
1,614
– – ﹤0.01% 1523
2019
Q3 		$49.6K Hold
1,614
– – ﹤0.01% 1477
2019
Q2 		$32.2K Hold
1,614
– – ﹤0.01% 1595
2019
Q1 		$69.6K Hold
1,614
– – ﹤0.01% 1236
2018
Q4 		$51.4K Hold
1,614
– – ﹤0.01% 1276
2018
Q3 		$84.8K Hold
1,614
– – ﹤0.01% 1219
2018
Q2 		$86.5K Hold
1,614
– – ﹤0.01% 1221
2018
Q1 		$80.7K Hold
1,614
– – ﹤0.01% 1217
2017
Q4 		$53.1K Hold
1,614
– – ﹤0.01% 1323
2017
Q3 		$60.7K Hold
1,614
– – ﹤0.01% 1271
2017
Q2 		$41.2K Hold
1,614
– – ﹤0.01% 1418
2017
Q1 		$42K Buy
+1,614
New +$46.5K ﹤0.01% 1168

Other funds holding HBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's HBIO Position: Q2 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Harvard Bioscience (HBIO) in Q2 2020, closing a stake of 1,614 shares — an estimated $36.1K sold.

Federation des caisses Desjardins du Quebec first reported a position in HBIO in Q1 2017 and held it in 13 quarters. The position peaked at $86.5K in Q2 2018. 87 funds tracked by Wall St. Rank hold HBIO as of Q2 2020.

  • Federation des caisses Desjardins du Quebec reported no remaining Harvard Bioscience position as of Q2 2020 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 1,614 Harvard Bioscience shares in Q2 2020, an estimated $36.1K.
  • Federation des caisses Desjardins du Quebec first reported a position in Harvard Bioscience in Q1 2017 and held it in 13 quarters.
  • Federation des caisses Desjardins du Quebec's Harvard Bioscience position peaked at $86.5K in Q2 2018.
  • 87 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2020, filed 30 Aug 2024.